LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Innovating customized stents for the treatment of bronchopleural fistula.

Photo by schluditsch from unsplash

Central bronchopulmonary fistulae (BPF) are associated with high morbidity and mortality (1,2). They occur as an uncommon, but often severe, complication of surgical procedures involving pulmonary resection, in particular pneumonectomy,… Click to show full abstract

Central bronchopulmonary fistulae (BPF) are associated with high morbidity and mortality (1,2). They occur as an uncommon, but often severe, complication of surgical procedures involving pulmonary resection, in particular pneumonectomy, with an estimated incidence ranging between 3% up to 28% (3,4). The incidence of BPF following lobectomy is significantly lower (0.5%) (3). The mortality rate associated with BPF ranges from 16% to 72% (3,4). This complication is significantly more common in patients with malignancy, poor nutritional status, and prior chemotherapy or radiotherapy.

Keywords: bronchopleural fistula; treatment bronchopleural; stents treatment; innovating customized; customized stents

Journal Title: Journal of thoracic disease
Year Published: 2019

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.